Wellgistics Health CEO Tim Canning to Exit, Brian Norton Named Successor

Dow Jones

03-05

By Sabela Ojea

Wellgistics Health said Chief Executive Tim Canning is leaving after about a year in the role and will be succeeded by Brian Norton.

The holding company centered around pharmaceuticals and healthcare services on Tuesday said that the appointment of Norton comes at a pivotal time for the company as it continues to streamline operations and expand market reach.

Under his leadership, the company will focus on enhancing operational efficiencies, optimizing sales and marketing strategies, advancing its technology roadmap, and remaining disciplined in executing on acquisition opportunities.

Norton has a proven track record of success and expertise in healthcare, technology, and pharmaceutical supply chain innovation and has led high-performing teams to accelerate market growth and revenue recognition, the company said.

Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix

(END) Dow Jones Newswires

March 04, 2025 17:35 ET (22:35 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2517898778"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2517898778\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2517898778?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-05 06:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2517898778","market":"other","top_or_hot":-1,"title":"Wellgistics Health CEO Tim Canning to Exit, Brian Norton Named Successor","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Sabela Ojea \n</p>\n<pre>\n \n</pre>\n<p>\n  Wellgistics Health said Chief Executive Tim Canning is leaving after about a year in the role and will be succeeded by Brian Norton. \n</p>\n<p>\n  The holding company centered around pharmaceuticals and healthcare services on Tuesday said that the appointment of Norton comes at a pivotal time for the company as it continues to streamline operations and expand market reach. \n</p>\n<p>\n  Under his leadership, the company will focus on enhancing operational efficiencies, optimizing sales and marketing strategies, advancing its technology roadmap, and remaining disciplined in executing on acquisition opportunities. \n</p>\n<p>\n  Norton has a proven track record of success and expertise in healthcare, technology, and pharmaceutical supply chain innovation and has led high-performing teams to accelerate market growth and revenue recognition, the company said. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 04, 2025 17:35 ET (22:35 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wellgistics Health CEO Tim Canning to Exit, Brian Norton Named Successor</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWellgistics Health CEO Tim Canning to Exit, Brian Norton Named Successor\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-03-05 06:35</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Sabela Ojea \n</p>\n<pre>\n \n</pre>\n<p>\n  Wellgistics Health said Chief Executive Tim Canning is leaving after about a year in the role and will be succeeded by Brian Norton. \n</p>\n<p>\n  The holding company centered around pharmaceuticals and healthcare services on Tuesday said that the appointment of Norton comes at a pivotal time for the company as it continues to streamline operations and expand market reach. \n</p>\n<p>\n  Under his leadership, the company will focus on enhancing operational efficiencies, optimizing sales and marketing strategies, advancing its technology roadmap, and remaining disciplined in executing on acquisition opportunities. \n</p>\n<p>\n  Norton has a proven track record of success and expertise in healthcare, technology, and pharmaceutical supply chain innovation and has led high-performing teams to accelerate market growth and revenue recognition, the company said. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 04, 2025 17:35 ET (22:35 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4175","symbol_name":"保健護理產品經銷商","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2517898778","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2517898778","pubTimestamp":1741127700,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Wellgistics Health said Chief Executive Tim Canning is leaving after about a year in the role and will be succeeded by Brian Norton.The holding company centered around pharmaceuticals and healthcare services on Tuesday said that the appointment of Norton comes at a pivotal time for the company as it continues to streamline operations and expand market reach.Under his leadership, the company will focus on enhancing operational efficiencies, optimizing sales and marketing strategies, advancing its technology roadmap, and remaining disciplined in executing on acquisition opportunities.Norton has a proven track record of success and expertise in healthcare, technology, and pharmaceutical supply chain innovation and has led high-performing teams to accelerate market growth and revenue recognition, the company said.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4175":"保健护理产品经销商","BK4132":"无线电信业务","TIMB":"TIM","WGRX":"Wellgistics Health Inc."},"translate_title":"Wellgistics Health首席执行官蒂姆·坎宁(Tim Canning)退出，布莱恩·诺顿(Brian Norton)被任命为继任者","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TIMB":1,"WGRX":1},"content_text":"By Sabela Ojea \n\n\n \n\n\n  Wellgistics Health said Chief Executive Tim Canning is leaving after about a year in the role and will be succeeded by Brian Norton. \n\n\n  The holding company centered around pharmaceuticals and healthcare services on Tuesday said that the appointment of Norton comes at a pivotal time for the company as it continues to streamline operations and expand market reach. \n\n\n  Under his leadership, the company will focus on enhancing operational efficiencies, optimizing sales and marketing strategies, advancing its technology roadmap, and remaining disciplined in executing on acquisition opportunities. \n\n\n  Norton has a proven track record of success and expertise in healthcare, technology, and pharmaceutical supply chain innovation and has led high-performing teams to accelerate market growth and revenue recognition, the company said. \n\n\n \n\n\n  Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 04, 2025 17:35 ET (22:35 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":1}}}